Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00161
|
|||||
| EM Name |
Estradiol-17beta-glucuronide
|
|||||
| Synonyms |
Estradiol-17beta-glucuronide; Glucuronosylestradiol; 17beta-estradiol 17-glucosiduronic acid; 17beta-Estradiol 17-(beta-D-glucuronide); CHEMBL1697724; 3-hydroxyestra-1,3,5(10)-trien-17beta-yl beta-D-glucopyranosiduronic acid; 17beta-estradiol-17-(beta-D-glucuronide); 17; A-Estradiol 17; A-D-Glucuronide; [3H]estradiol-17beta-glucuronide; [3H]-estradiol-17beta-glucuronide; AC1NQZ8R; Estradiol 17-Glucuronide; estradiol 17b glucuronide; Estradiol-17B-Glucuronide; SCHEMBL57240; GTPL4687; ZINC4099035
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5281887"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C24H32O8
|
|||||
| Canonical SMILES |
CC12CCC3C(C1CCC2OC4C(C(C(C(O4)C(=O)O)O)O)O)CCC5=C3C=CC(=C5)O
|
|||||
| InChI |
InChI=1S/C24H32O8/c1-24-9-8-14-13-5-3-12(25)10-11(13)2-4-15(14)16(24)6-7-17(24)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-21,23,25-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,17+,18+,19+,20-,21+,23-,24+/m1/s1
|
|||||
| InChIKey |
MTKNDAQYHASLID-QXYWQCSFSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 448.5 | Topological Polar Surface Area | 137 | ||
| Heavy Atom Count | 32 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
2.7
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:791
|
|||||
| DT(s) "handling" This EM | BSEP | Transporter Info | Bile salt export pump | [1] | ||
| MRP7 | Transporter Info | Multidrug resistance-associated protein 7 | [2] | |||
| P-GP | Transporter Info | P-glycoprotein 1 | [3] | |||
| References | ||||||
| 1 | Beyond Competitive Inhibition: Regulation of ABC Transporters by Kinases and Protein-Protein Interactions as Potential Mechanisms of Drug-Drug Interactions. Drug Metab Dispos. 2018 May;46(5):567-580. | |||||
| 2 | Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr Med Chem. 2008;15(20):1981-2039. | |||||
| 3 | MDR1 substrates/modulators protect against beta-estradiol-17beta-D-glucuronide cholestasis in rat liver. Cancer Res. 1996 Nov 1;56(21):4992-7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.